Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 314
7
Diseases
7
Unique genes
0.260
Avg. similarity score
Cortical occipital malformations
Most-connected disease (5 links)
Disease
Searched: Abnormal cortical gyration
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Abnormal cortical gyration
Cortical occipital malformations
Intellectual developmental disorder autism speech
Developmental delay with language impairment and movement disorder
Intellectual developmental disorder speech autism dysmorphic
Intellectual developmental disorder with autistic features and language delay, with or without seizures
Occipital pachygyria and polymicrogyria
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Cortical occipital malformations | 5 | 5 | 2 |
| Intellectual developmental disorder autism speech | 5 | 5 | 2 |
| Abnormal cortical gyration | 4 | 4 | 1 |
| Developmental delay with language impairment and movement disorder | 4 | 4 | 2 |
| Intellectual developmental disorder speech autism dysmorphic | 4 | 4 | 4 |
| Intellectual developmental disorder with autistic features and language delay, with or without seizures | 1 | 1 | 1 |
| Occipital pachygyria and polymicrogyria | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TBR1 | 5 / 7 | Abnormal cortical gyration, Cortical occipital malformations, Developmental delay with language impairment and movement disorder, Intellectual developmental disorder autism speech and 1 more |
| LAMC3 | 2 / 7 | Cortical occipital malformations, Occipital pachygyria and polymicrogyria |
| TANC2 | 2 / 7 | Intellectual developmental disorder autism speech, Intellectual developmental disorder with autistic features and language delay, with or without seizures |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
None of these pathways reaches significance (all FDR q ≥ 0.05). They’re the best candidates found, but treat them as weak evidence for why this cluster groups together.
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | Reactome | 1 / 20 | 85.8× | 1.16e-2 | 6.22e-2 |
| Deadenylation of mRNA | Reactome | 1 / 24 | 71.5× | 1.39e-2 | 6.94e-2 |
| Laminin interactions | Reactome | 1 / 28 | 61.3× | 1.62e-2 | 7.59e-2 |
| MET activates PTK2 signaling | Reactome | 1 / 30 | 57.2× | 1.74e-2 | 7.88e-2 |
| Nuclear Receptor transcription pathway | Reactome | 1 / 52 | 33.0× | 2.99e-2 | 1.08e-1 |
| RNA degradation | KEGG | 1 / 78 | 22.0× | 4.46e-2 | 1.36e-1 |
| ECM-receptor interaction | KEGG | 1 / 89 | 19.3× | 5.07e-2 | 1.46e-1 |
| Small cell lung cancer | KEGG | 1 / 93 | 18.4× | 5.30e-2 | 1.49e-1 |
| Aldosterone synthesis and secretion | KEGG | 1 / 98 | 17.5× | 5.58e-2 | 1.54e-1 |
| Amoebiasis | KEGG | 1 / 103 | 16.7× | 5.85e-2 | 1.58e-1 |
| Toxoplasmosis | KEGG | 1 / 112 | 15.3× | 6.35e-2 | 1.66e-1 |
| Parathyroid hormone synthesis, secretion and action | KEGG | 1 / 115 | 14.9× | 6.51e-2 | 1.69e-1 |
| Estrogen-dependent gene expression | Reactome | 1 / 150 | 11.4× | 8.42e-2 | 1.95e-1 |
| Focal adhesion | KEGG | 1 / 203 | 8.5× | 1.13e-1 | 2.32e-1 |
| Human papillomavirus infection | KEGG | 1 / 333 | 5.2× | 1.79e-1 | 3.08e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| general adaptation syndrome | GO:0051866 | 1 / 1 | 2,670× | 3.75e-4 | 7.81e-3 ✓ sig. |
| specification of animal organ identity | GO:0010092 | 1 / 1 | 2,670× | 3.75e-4 | 7.81e-3 ✓ sig. |
| conditioned taste aversion | GO:0001661 | 1 / 3 | 890× | 1.12e-3 | 1.55e-2 ✓ sig. |
| habenula development | GO:0021986 | 1 / 3 | 890× | 1.12e-3 | 1.55e-2 ✓ sig. |
| amygdala development | GO:0021764 | 1 / 4 | 667× | 1.50e-3 | 1.82e-2 ✓ sig. |
| dense core granule cytoskeletal transport | GO:0099519 | 1 / 4 | 667× | 1.50e-3 | 1.82e-2 ✓ sig. |
| cellular response to corticotropin-releasing hormone stimulus | GO:0071376 | 1 / 5 | 534× | 1.87e-3 | 2.05e-2 ✓ sig. |
| nucleosome organization | GO:0034728 | 1 / 6 | 445× | 2.25e-3 | 2.24e-2 ✓ sig. |
| commitment of neuronal cell to specific neuron type in forebrain | GO:0021902 | 1 / 6 | 445× | 2.25e-3 | 2.24e-2 ✓ sig. |
| regulation of axon guidance | GO:1902667 | 1 / 6 | 445× | 2.25e-3 | 2.24e-2 ✓ sig. |
| regulation of respiratory gaseous exchange | GO:0043576 | 1 / 6 | 445× | 2.25e-3 | 2.24e-2 ✓ sig. |
| dopamine biosynthetic process | GO:0042416 | 1 / 9 | 297× | 3.37e-3 | 2.76e-2 ✓ sig. |
| regulation of dopamine metabolic process | GO:0042053 | 1 / 9 | 297× | 3.37e-3 | 2.76e-2 ✓ sig. |
| central nervous system projection neuron axonogenesis | GO:0021952 | 1 / 9 | 297× | 3.37e-3 | 2.76e-2 ✓ sig. |
| regulation of dendritic spine development | GO:0060998 | 1 / 10 | 267× | 3.74e-3 | 2.90e-2 ✓ sig. |